Table 2.
Baseline patient characteristics of late diffuse recurrence (LDR) patients.
| Characteristic· | S-TACE (n=39) | TACE (n=141) | P value |
|---|---|---|---|
| Sex | 0.247 | ||
| Male Female |
36(92.3) 3(7.7) |
127(90.1) 14(9.9) |
|
| Age(y) | 0.428 | ||
| Mean±SD Range |
52.0±12.8 22–76 |
57.0±12.3 22-78 |
|
| Cause of HCC | 0.613 | ||
| HBV HCV Alcohol Other |
33(84.6) 3(7.7) 1(2.6) 2(5.1) |
124(87.9) 6(4.3) 4(2.8) 7(5.0) |
|
| Liver cirrhosis | 31(79.5) | 110(78.0) | 0.844 |
| ALB(g/L) Mean±SD Range |
36.0±4.4 27–47 |
35.0±6.3 24–66 |
0.262 |
| TB (umol/L) | 0.088 | ||
| Mean ± SD Range |
21.0±10.1 7.9-39.0 |
14.9±9.8 7.6-41.0 |
|
| AFP(ng/ml) | 0.833 | ||
| ≥400 <400 |
19(48.7) 20(51.3) |
66(46.8) 75(53.2) |
|
| HBV-DNA(U/ml) | 0.062 | ||
| ≥100 <100 |
10(25.6) 29(74.4) |
59(41.8) 82(58.2) |
|
| ECOG | 0.247 | ||
| 0 1 |
33(84.6) 6(15.4) |
107(75.9) 34(24.1) |
|
| Child-Pugh | 0.276 | ||
| A B |
32(82.1) 7(17.9) |
125(88.7) 16(11.3) |
|
| Maximal tumor diameter(cm) | 0.279 | ||
| Mean ± SD Range |
6.0±3.3 1.0–15.0 |
5.0±3.2 1.0–16.0 |
Except where indicated, data are numbers of patients. Data in parentheses are percentages and were calculated by using the total number of patients in each group as the denominator.